Emergo Therapeutics Board of Directors Welcomes Jack Bailey, President, GSK Pharmaceuticals USA

DURHAM, N.C., May 30, 2019 -- (Healthcare Sales & Marketing Network) -- Emergo Therapeutics, which continues to accelerate its lead candidate norketotifen through Phase 2 studies, has added another seasoned executive to its Board of Directors. Jack Bailey... Biopharmaceuticals, Personnel Emergo Therapeutics, norketotifen, influenza
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news